280 related articles for article (PubMed ID: 27376534)
21. Location of the cross-β structure in prion fibrils: A search by seeding and electron spin resonance spectroscopy.
Chu BK; Tsai RF; Hung CL; Kuo YH; Chen EH; Chiang YW; Chan SI; Chen RP
Protein Sci; 2022 Jun; 31(6):e4326. PubMed ID: 35634767
[TBL] [Abstract][Full Text] [Related]
22. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
[TBL] [Abstract][Full Text] [Related]
23. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
24. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
25. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
26. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
[TBL] [Abstract][Full Text] [Related]
27. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
[TBL] [Abstract][Full Text] [Related]
28. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
29. Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.
Race B; Williams K; Hughson AG; Jansen C; Parchi P; Rozemuller AJM; Chesebro B
Acta Neuropathol Commun; 2018 Feb; 6(1):13. PubMed ID: 29458424
[TBL] [Abstract][Full Text] [Related]
30.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
31. Synthetic prions with novel strain-specified properties.
Moda F; Le TN; Aulić S; Bistaffa E; Campagnani I; Virgilio T; Indaco A; Palamara L; Andréoletti O; Tagliavini F; Legname G
PLoS Pathog; 2015 Dec; 11(12):e1005354. PubMed ID: 26720726
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.
Aulić S; Masperone L; Narkiewicz J; Isopi E; Bistaffa E; Ambrosetti E; Pastore B; De Cecco E; Scaini D; Zago P; Moda F; Tagliavini F; Legname G
Sci Rep; 2017 Aug; 7(1):10050. PubMed ID: 28855681
[TBL] [Abstract][Full Text] [Related]
33. Porcine prion protein amyloid.
Hammarström P; Nyström S
Prion; 2015; 9(4):266-77. PubMed ID: 26218890
[TBL] [Abstract][Full Text] [Related]
34. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.
Manson JC; Jamieson E; Baybutt H; Tuzi NL; Barron R; McConnell I; Somerville R; Ironside J; Will R; Sy MS; Melton DW; Hope J; Bostock C
EMBO J; 1999 Dec; 18(23):6855-64. PubMed ID: 10581259
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
36. Segments in the Amyloid Core that Distinguish Hamster from Mouse Prion Fibrils.
Shen HC; Chen YH; Lin YS; Chu BK; Liang CS; Yang CC; Chen RP
Neurochem Res; 2019 Jun; 44(6):1399-1409. PubMed ID: 30603982
[TBL] [Abstract][Full Text] [Related]
37. Prion-like aggregates: infectious agents in human disease.
Westermark GT; Westermark P
Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
[TBL] [Abstract][Full Text] [Related]
38. The seeding barrier between human and Syrian hamster prion protein amyloid fibrils is determined by β2-α2 loop sequence elements.
Šulskis D; Šneiderienė G; Žiaunys M; Smirnovas V
Int J Biol Macromol; 2023 May; 238():124038. PubMed ID: 36921824
[TBL] [Abstract][Full Text] [Related]
39. Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.
Sevillano AM; Aguilar-Calvo P; Kurt TD; Lawrence JA; Soldau K; Nam TH; Schumann T; Pizzo DP; Nyström S; Choudhury B; Altmeppen H; Esko JD; Glatzel M; Nilsson KPR; Sigurdson CJ
J Clin Invest; 2020 Mar; 130(3):1350-1362. PubMed ID: 31985492
[TBL] [Abstract][Full Text] [Related]
40. 2.7 Å cryo-EM structure of ex vivo RML prion fibrils.
Manka SW; Zhang W; Wenborn A; Betts J; Joiner S; Saibil HR; Collinge J; Wadsworth JDF
Nat Commun; 2022 Jul; 13(1):4004. PubMed ID: 35831275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
